Morristown-based dosage solution company Capsugel announced Thursday it will acquire Oregon-based Bend Research.
The companies said Capsugel will absorb Bend into its dosage form solutions business unit, first announced in February. Financial terms were not disclosed.
According to the announcement, Bend Research complements Capsugel DFS's existing customer offerings with capabilities that support new compound development and enable improved life cycle management for existing products across pharmaceutical and nutritional markets.
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy